DELUCA HECTOR F,NEHRING JAMIE,RUDOLPH EHREN N,PLUM LORI
申请号：
NZ59983310
公开号：
NZ599833A
申请日:
2010.10.21
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
599833 Disclosed is a method of preventing Type 1 diabetes in a subject at risk of developing Type 1 diabetes, the method comprising administering to the subject a therapeutically effective amount of 2a-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3, wherein Type 1 diabetes is prevented from developing in the subject without inducing hypercalcemia in the subject.
